Peter J. Stein, PhD, DC

Researchers sought to apply the clinical trial eligibility criteria for lecanemab and aducanumab treatment to patients with early AD from the MCSA study and assessed the generalizability of anti-amyloid treatment.

Although this year’s ultra-high rates of RSV hospitalizations have recently fallen, certain features of this season’s outbreak set it apart from those of previous years.